New York, New York, United States Delos is the famous Corporate Investor, which was founded in 2007. The main department of described Corporate Investor is located in the New York. The fund was located in North America if to be more exact in United States.
The usual cause for the fund is to invest in rounds with 8 partakers. Despite the Delos, startups are often financed by EASME - EU Executive Agency for SMEs. The meaningful sponsors for the fund in investment in the same round are Sitra, Leena Niemistu00f6, Jasper Pu00e4u00e4kku00f6nen.
This organization was formed by Paul Scialla.
For fund there is no match between the location of its establishment and the land of its numerous investments - Finland. We can highlight the next thriving fund investment areas, such as Health Care, GreenTech. Among the most popular portfolio startups of the fund, we may highlight Naava.
The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 1 - 5 millions dollars. The important activity for fund was in 2017.
| Fund Name | Location |
| Amura Capital | - |
| Blue9 Technologies | India, Noida, Uttar Pradesh |
| DBT Group | - |
| Giving Wings | - |
| Hunan Jingfeng Pharmaceutical | Baoshan District, China |
| Main Street Advisors | Chicago, Illinois, United States |
| Turk Telekom PILOT | Istanbul, Istanbul, Turkey |
| UMJ Ikeya Investment | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Kaiterra | 01 Oct 2017 | Crans-Montana, Wallis, Switzerland |
– LifeQ, a provider of biometrics and health information derived from wearable devices and used in health management solutions, raised $47m.
– The round was led by Invenfin, 4Di Capital, Allectus Capital, Mogul Capital, Tenhong Holdings, Analog Devices, Hannover Re, Convergence Partners, Stellar Capital Partners, Nedbank Corporate and Investment Bank, Delos, OneBio Seed Investment Fund, Virgin Group, Lireas, Allen & Co, and Acequia Capital.
– The new investment will be used to accelerate the company’s global expansion and development of new products.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Kaiterra | 01 Oct 2017 | Crans-Montana, Wallis, Switzerland |
